Evidence map›Paper›PMID 30215766›Full record

ArticleNucleic acids research2019

CRISPR-Cap: multiplexed double-stranded DNA enrichment based on the CRISPR system.

Jeewon Lee, Hyeonseob Lim, Hoon Jang, Byungjin Hwang, Joon Ho Lee, Junhyuk Cho, Ji Hyun Lee, Duhee Bang

Abstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cas9-based enrichment and single-molecule sequencing for precise characterization of genomic duplications.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeewon LeeDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Hyeonseob LimDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Hoon JangDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Byungjin HwangDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Joon Ho LeeDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Junhyuk ChoDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Ji Hyun LeeDepartment of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Duhee BangDepartment of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing methods to enrich target regions of genomic DNA based on PCR, hybridization capture, or molecular inversion probes have various drawbacks, including long experiment times and low throughput and/or enrichment quality. We developed CRISPR-Cap, a simple and scalable CRISPR-based method to enrich target regions of dsDNA, requiring only two short experimental procedures that can be completed within two hours. We used CRISPR-Cap to enrich 10 target genes 355.7-fold on average from Escherichia coli genomic DNA with a maximum on-target ratio of 81% and high enrichment uniformity. We also used CRISPR-Cap to measure gene copy numbers and detect rare alleles with frequencies as low as 1%. Finally, we enriched coding sequence regions of 20 genes from the human genome. We envision that CRISPR-Cap can be used as an alternative to other widely used target-enrichment methods, which will broaden the scope of CRISPR applications to the field of target enrichment field.

Indexed as

AllelesCRISPR-Cas SystemsDNAEscherichia coliGenome, BacterialGenome, HumanHumansSequence Analysis, DNADNA

Identifiers

PMID30215766
PMCPMC6326800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.